Mortality of patients with COPD

References

• Safiri S, Carson-Chahhoud K, Noori M, et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the global burden of disease study 2019. BMJ. 2022 Jul 27;378:e069679. doi: 10.1136/bmj-2021-069679
   PubMedGoogle Scholar
• Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet. 1997 May 24;349(9064):1498–1504. doi: 10.1016/S0140-6736(96)07492-2
   PubMed Web of Science ®Google Scholar
• Lortet-Tieulent J, Soerjomataram I, Lopez-Campos JL, et al. International trends in COPD mortality, 1995-2017. Eur Respir J. 2019 Dec;54(6):1901791. doi: 10.1183/13993003.01791-2019
   PubMed Web of Science ®Google Scholar
• Hansell AL, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J. 2003 Nov;22(5):809–814. doi: 10.1183/09031936.03.00031403
   PubMed Web of Science ®Google Scholar
• Mannino DM, Brown C, Giovino GA. Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):814–818. doi: 10.1164/ajrccm.156.3.9702026
   PubMed Web of Science ®Google Scholar
• Meyer PA, Mannino DM, Redd SC, et al. Characteristics of adults dying with COPD. Chest. 2002 Dec;122(6):2003–2008. doi: 10.1378/chest.122.6.2003
   PubMed Web of Science ®Google Scholar
• Jensen HH, Godtfredsen NS, Lange P, et al. Potential misclassification of causes of death from COPD in a Danish population study. Eur Respir J. 2006 Jun 28;28(4):781–785. doi: 10.1183/09031936.06.00152205
   PubMed Web of Science ®Google Scholar
• Fuhrman C, Jougla E, Nicolau J, et al. Chronic obstructive pulmonary disease deaths in France, 1979-2002: a multiple-cause analysis. Thorax. 2006 May 31;61(11):930–934. doi: 10.1136/thx.2006.061267
   PubMed Web of Science ®Google Scholar
• Brock A, Griffiths C, Rooney C. The impact of introducing ICD-10 on analysis of respiratory mortality trends in England and Wales. Health Stat Q. 2006;(29):9–17.
   PubMedGoogle Scholar
• Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance–United States, 1971–2000. MMWR Surveill Summ. 2002 Aug 2;51(6):1–16.
   Google Scholar
• Halpin DMG, Celli BR, Criner GJ, et al. It is time for the world to take COPD seriously: a statement from the GOLD board of directors. Eur Respir J. 2019 Jul;54(1):1900914. doi: 10.1183/13993003.00914-2019
   PubMed Web of Science ®Google Scholar
• Liu W, Wang W, Liu J, et al. Trend of mortality and years of life lost due to chronic obstructive pulmonary disease in China and its provinces, 2005-2020. Int J Chron Obstruct Pulmon Dis. 2021;16:2973–2981. doi: 10.2147/COPD.S330792
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Celli BR, Criner GJ, et al. The GOLD summit on chronic obstructive pulmonary disease in low- and middle-income countries. Int J Tuberc Lung Dis. 2019 Nov 1;23(11):1131–1141. doi: 10.5588/ijtld.19.0397
   PubMed Web of Science ®Google Scholar
• OECD, European Union. Health at a glance: Europe 2018: state of health in the EU cycle. Paris: OECD Publishing; 2018. ( Health at a Glance: Europe.
   Google Scholar
• Quach A, Giovannelli J, Cherot-Kornobis N, et al. Prevalence and underdiagnosis of airway obstruction among middle-aged adults in northern France: the ELISABET study 2011-2013. Respir Med. 2015 Dec;109(12):1553–1561. doi: 10.1016/j.rmed.2015.10.012
   PubMed Web of Science ®Google Scholar
• Global Burden of Disease Collaborative Network. Global burden of disease study 2019 (GBD 2019) results. Seatle: Institute for Health Metrics and Evaluation (IHME); 2020. https://vizhub.healthdata.org/gbd-results/
   Google Scholar
• Marks GB, Burney P. Diseases of the respiratory system. In: Charlton J, Murphy M, editors. The health of adult britain. London: Office for National Statistics; 1998. p. 1841–1994.
   Google Scholar
• Widdicombe JH. A brief history of bronchitis in England and wales. Chronic Obstr Pulm Dis. 2020 Oct;7(4):303–314. doi: 10.15326/jcopdf.7.4.2020.0135
   PubMed Web of Science ®Google Scholar
• Collis EL. The general and occupational prevalence of bronchitis and its relation to other respiratory diseases. J Ind Hyg Toxicol. 1923;5:264–276.
   Google Scholar
• Goodman N, Lane RE, Rampling SB. Chronic bronchitis: an introductory examination of existing data. Br Med J. 1953 Aug 1;2(4830):237–243. doi: 10.1136/bmj.2.4830.237
   PubMedGoogle Scholar
• Logan WP. Social class variations in mortality. Br J Preventative & Soc Med. 1954 Jul;8(3):128–137. doi: 10.1136/jech.8.3.128
   PubMedGoogle Scholar
• Evandrou M, Falkingham J. Smoking behaviour and socio-economic status: a cohort analysis, 1974-1998. Health Stat Q. 2002;14:30–39.
   Google Scholar
• The Registrar General. Decennial Supplement, England and Wales, 1961: Area mortality tables. London: H.M. Stationery Office; 1967.
   Google Scholar
• Britton M, editor. Mortality and geography: a review in the mid-1980s: the Registrar General’s decennial supplement for England and Wales. London: HMSO; 1990.
   Google Scholar
• Lewer D, Jayatunga W, Aldridge RW, et al. Premature mortality attributable to socioeconomic inequality in England between 2003 and 2018: an observational study. The Lancet Public Health. 2020 Jan;5(1):e33–e41. doi: 10.1016/S2468-2667(19)30219-1
   PubMed Web of Science ®Google Scholar
• Rasmussen FV, Borchsenius L, Winsløw JB, et al. Associations between housing conditions, smoking habits and ventilatory lung function in men with clean jobs. Scand J Respir Dis. 1978 Oct;59(5):264–276.
   PubMedGoogle Scholar
• Levin KA, Anderson D, Crighton E. Prevalence of COPD by age, sex, socioeconomic position and smoking status; a cross-sectional study. Health Educ. 2020;120(5/6):275–288. doi: 10.1108/HE-06-2020-0044
   Web of Science ®Google Scholar
• Collins PF, Stratton RJ, Kurukulaaratchy RJ, et al. Influence of deprivation on health care use, health care costs, and mortality in COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:1289–1296. doi: 10.2147/COPD.S157594
   PubMed Web of Science ®Google Scholar
• Coggon D, Barker DJ, Inskip H, et al. Housing in early life and later mortality. J Epidemiol Community Health. 1993 Oct;47(5):345–348. doi: 10.1136/jech.47.5.345
   PubMed Web of Science ®Google Scholar
• Hatton TJ. Infant mortality and the health of survivors: Britain, 1910–50. Econ Hist Rev. 2011;64(3):951–972. doi: 10.1111/j.1468-0289.2010.00572.x
   PubMed Web of Science ®Google Scholar
• Barker DJ, Godfrey KM, Fall C, et al. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ. 1991 Sep 21;303(6804):671–675. doi: 10.1136/bmj.303.6804.671
   PubMed Web of Science ®Google Scholar
• Schneider EB. Fetal health stagnation: have health conditions in utero improved in the United States and Western and Northern Europe over the past 150 years? Soc Sci Med. 2017 Apr;179:18–26. doi: 10.1016/j.socscimed.2017.02.018
   PubMed Web of Science ®Google Scholar
• Woods RI, Watterson PA, Woodward JH. The causes of rapid infant mortality decline in England and Wales, 1861- 1921 part I. Popul Stud (Camb). 1988 Nov;42(3):343–366. doi: 10.1080/0032472031000143516
   PubMed Web of Science ®Google Scholar
• Loudon I. On maternal and infant mortality 1900–1960. Soc Hist Med. 1991 Apr;4(1):29–73. doi: 10.1093/shm/4.1.29
   PubMed Web of Science ®Google Scholar
• Auliciems A, Burton I. Trends in smoke concentrations before and after the clean air act of 1956. Atmos Environ (1967). 1973 Nov;7(11):1063–1070. doi: 10.1016/0004-6981(73)90215-1
   PubMed Web of Science ®Google Scholar
• Brimblecombe P. The clean air Act after 50 years. Weather. 2006;61(11):311–314. doi: 10.1256/wea.127.06
   Google Scholar
• Laxen DP, Thompson MA. Sulphur dioxide in Greater London, 1931-1985. Environ Pollut. 1987;43(2):103–114. doi: 10.1016/0269-7491(87)90069-8
   PubMed Web of Science ®Google Scholar
• Stocks P. Cancer and bronchitis mortality in relation to atmospheric deposit and smoke. Br Med J. 1959 Jan 10;1(5114):74–79. doi: 10.1136/bmj.1.5114.74
   PubMedGoogle Scholar
• Christensen OW, Wood CH. Bronchitis mortality rates in England and Wales and in Denmark. Br Med J. 1958 Mar 15;1(5071):620–622. doi: 10.1136/bmj.1.5071.620
   PubMedGoogle Scholar
• Wald N, Nicolaides-Bouman A. UK smoking statistics. 2nd ed. Oxford: Oxford University Press; 1991.
   Google Scholar
• Office for National Statistics (ONS). Adult smoking habits in the UK: 2019. London: ONS website; 2020. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/bulletins/adultsmokinghabitsingreatbritain/2019#:~:text=In%20the%20UK%20population%20in,Annual%20Population%20Survey%20(APS)
   Google Scholar
• Doll R, Darby S, Whitely E. Trends in mortality from smoking-related diseases. In: Charlton J Murphy M, editors. The health of adult britain. London: Office for National Statistics; 1998. p. 1841–1994.
   Google Scholar
• Royal College of Physicians. Fifty years since smoking and health. Progress, lessons and priorities for a smoke-free UK. In: Report of conference proceedings; London. RCP; 2012.
   Google Scholar
• Office National Statistics. Adult smoking habits in the UK: 2019. [cited 2024 Jan]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/bulletins/adultsmokinghabitsingreatbritain/2019
   Google Scholar
• Brown CA, Crombie IK, Tunstall-Pedoe H. Failure of cigarette smoking to explain international differences in mortality from chronic obstructive pulmonary disease. J Epidemiol Community Health. 1994 Apr;48(2):134–139. doi: 10.1136/jech.48.2.134
   PubMed Web of Science ®Google Scholar
• Burney P, Jithoo A, Kato B, et al. Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty–a BOLD analysis. Thorax. 2014 May;69(5):465–473. doi: 10.1136/thoraxjnl-2013-204460
   PubMed Web of Science ®Google Scholar
• Lee PN, Fry JS, Forey BA. Trends in lung cancer, chronic obstructive lung disease, and emphysema death rates for England and Wales 1941-85 and their relation to trends in cigarette smoking. Thorax. 1990 Sep;45(9):657–665. doi: 10.1136/thx.45.9.657
   PubMed Web of Science ®Google Scholar
• Adair T, Hoy D, Dettrick Z, et al. 100 years of mortality due to chronic obstructive pulmonary disease in Australia: the role of tobacco consumption. Int J Tuberc Lung Dis. 2012 Dec;16(12):1699–1705. doi: 10.5588/ijtld.12.0251
   PubMed Web of Science ®Google Scholar
• Dorn HF. The increasing mortality from chronic respiratory diseases. Amer Stat Ass Proc Soc Stat Sec. 1961:148–153.
   Google Scholar
• Kiddle SJ, Whittaker HR, Seaman SR, et al. Prediction of five-year mortality after COPD diagnosis using primary care records. PLOS ONE. 2020;15(7):e0236011. doi: 10.1371/journal.pone.0236011
   PubMed Web of Science ®Google Scholar
• Afonso AS, Verhamme KM, Sturkenboom MC, et al. COPD in the general population: prevalence, incidence and survival. Respir Med. 2011 Dec;105(12):1872–1884. doi: 10.1016/j.rmed.2011.06.012
   PubMed Web of Science ®Google Scholar
• Lindberg A, Lundbäck B. The obstructive lung disease in Northern Sweden chronic obstructive pulmonary disease study: design, the first year participation and mortality. Clin Respir J. 2008 Oct;2(Suppl 1):64–71. doi: 10.1111/j.1752-699X.2008.00086.x
   PubMed Web of Science ®Google Scholar
• Gershon AS, Wang C, Wilton AS, et al. Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in ontario, Canada, 1996 to 2007: a population-based study. Arch Intern Med. 2010 Mar 22;170(6):560–565. doi: 10.1001/archinternmed.2010.17
   PubMed Web of Science ®Google Scholar
• Zysman M, Burgel PR, Court-Fortune I, et al. Relationship between gender and survival in a real-life cohort of patients with COPD. Respir Res. 2019 Aug 22;20(1):191. doi: 10.1186/s12931-019-1154-3
   PubMed Web of Science ®Google Scholar
• Colak Y, Afzal S, Nordestgaard BG, et al. Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in denmark: a prospective cohort study. The Lancet Respir Med. 2017 May;5(5):426–434. doi: 10.1016/S2213-2600(17)30119-4
   PubMed Web of Science ®Google Scholar
• Lange P, Colak Y, Ingebrigtsen TS, et al. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis. The Lancet Respir Med. 2016 Jun;4(6):454–462. doi: 10.1016/S2213-2600(16)00098-9
   PubMed Web of Science ®Google Scholar
• Gayle AV, Axson EL, Bloom CI, et al. Changing causes of death for patients with chronic respiratory disease in England, 2005-2015. Thorax. 2019 May;74(5):483–491. doi: 10.1136/thoraxjnl-2018-212514
   PubMed Web of Science ®Google Scholar
• Brown DW, Croft JB, Greenlund KJ, et al. Average age at death from COPD in the United States: 1980-85, 1990-95, 2000-05. COPD. 2009 Jun;6(3):152–154. doi: 10.1080/15412550902918428
   PubMedGoogle Scholar
• Vilkman S, Keistinen T, Tuuponen T, et al. Survival and cause of death among elderly chronic obstructive pulmonary disease patients after first admission to hospital. Respiration. 1997;64(4):281–284. doi: 10.1159/000196687
   PubMed Web of Science ®Google Scholar
• Sunyer J, Anto JM, McFarlane D, et al. Sex differences in mortality of people who visited emergency rooms for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 Sep;158(3):851–856. doi: 10.1164/ajrccm.158.3.9801093
   PubMed Web of Science ®Google Scholar
• Office for Health Improvement & Disparities. INteractive health atlas of lung conditions in England (INHALE): March 2023 update 2023. https://www.gov.uk/government/statistics/interactive-health-atlas-of-lung-conditions-in-england-inhale-march-2023-update/interactive-health-atlas-of-lung-conditions-in-england-inhale-march-2023-update
   Google Scholar
• Zielinski J, MacNee W, Wedzicha J, et al. Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch Chest Dis 1997 Feb;52(1):43–47.
   PubMedGoogle Scholar
• Halpin DMG, Martinez FJ. Pharmacotherapy and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2022 Nov 15;206(10):1201–1207. doi: 10.1164/rccm.202205-1000PP
   PubMed Web of Science ®Google Scholar
• Burrows B, Earle RH. Course and prognosis of chronic obstructive lung disease. A prospective study of 200 patients. N Engl J Med. 1969 Feb 20;280(8):397–404. doi: 10.1056/NEJM196902202800801
   PubMed Web of Science ®Google Scholar
• Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study. Am Rev Respir Dis. 1979 Jun;119(6):895–902.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease 1– 3. Am Rev Respir Dis. 1986 Jan;133(1):14–20. doi: 10.1164/arrd.1986.133.1.14
   PubMed Web of Science ®Google Scholar
• Halpin DMG. Bronchodilator responsiveness in asthma and COPD: time to stop chasing shadows. Am J Respir Crit Care Med. 2024 Jan 8;209(4):349–351. doi: 10.1164/rccm.202312-2248ED
   PubMed Web of Science ®Google Scholar
• Hansen EF, Phanareth K, Laursen LC, et al. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1267–1271. doi: 10.1164/ajrccm.159.4.9807121
   PubMed Web of Science ®Google Scholar
• Lundback B, Eriksson B, Lindberg A, et al. A 20-year follow-up of a population study-based COPD cohort-report from the obstructive lung disease in Northern Sweden studies. COPD: J Chronic Obstr Pulm Disease. 2009 Aug;6(4):263–271. doi: 10.1080/15412550903061483
   Web of Science ®Google Scholar
• Peto R, Speizer FE, Cochrane AL, et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis. 1983 Sep;128(3):491–500. doi: 10.1164/arrd.1983.128.3.491
   PubMed Web of Science ®Google Scholar
• Mannino DM, Buist AS, Petty TL, et al. Lung function and mortality in the United States: data from the First national health and nutrition examination survey follow up study. Thorax. 2003 May;58(5):388–393. doi: 10.1136/thorax.58.5.388
   PubMed Web of Science ®Google Scholar
• Gray-Donald K, Gibbons L, Shapiro SH, et al. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996 Mar;153(3):961–966. doi: 10.1164/ajrccm.153.3.8630580
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004 Mar 4;350(10):1005–1012. doi: 10.1056/NEJMoa021322
   PubMed Web of Science ®Google Scholar
• Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. The Lancet. 2009 Aug 29;374(9691):704–711. doi: 10.1016/S0140-6736(09)61301-5
   PubMed Web of Science ®Google Scholar
• Whittaker H, Rubino A, Müllerová H, et al. Frequency and severity of exacerbations of COPD associated with future risk of exacerbations and mortality: a UK routine health care data study. Int J Chron Obstruct Pulmon Dis. 2022;17:427–437. doi: 10.2147/COPD.S346591
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005 Nov;60(11):925–931. doi: 10.1136/thx.2005.040527
   PubMed Web of Science ®Google Scholar
• Celli B, Locantore N, Yates JC, et al. Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort. Eur Respir J. 2021 Mar;57(3):2001339. doi: 10.1183/13993003.01339-2020
   PubMed Web of Science ®Google Scholar
• Halpin DM, Miravitlles M, Metzdorf N, et al. Impact and prevention of severe exacerbations of COPD: a review of the evidence. Int J Chron Obstruct Pulmon Dis. 2017;12:2891–2908. doi: 10.2147/COPD.S139470
   PubMed Web of Science ®Google Scholar
• Garcia-Aymerich J, Serra Pons I, Mannino DM, et al. Lung function impairment, COPD hospitalisations and subsequent mortality. Thorax. 2011 Jul;66(7):585–590. doi: 10.1136/thx.2010.152876
   PubMed Web of Science ®Google Scholar
• Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003 Aug;124(2):459–467. doi: 10.1378/chest.124.2.459
   PubMed Web of Science ®Google Scholar
• Slenter RH, Sprooten RT, Kotz D, et al. Predictors of 1-year mortality at hospital admission for acute exacerbations of chronic obstructive pulmonary disease. Respiration. 2013;85(1):15–26. doi: 10.1159/000342036
   PubMed Web of Science ®Google Scholar
• Hurst JR, Quint JK, Stone RA, et al. National clinical audit for hospitalised exacerbations of COPD. ERJ Open Res. 2020 Jul;6(3):00208–2020. doi: 10.1183/23120541.00208-2020
   PubMedGoogle Scholar
• McGhan R, Radcliff T, Fish R, et al. Predictors of rehospitalization and death after a severe exacerbation of chronic obstructive pulmonary disease (COPD). Chest. 2007 Sep 21;132(6):1748–1755. doi: 10.1378/chest.06-3018
   PubMed Web of Science ®Google Scholar
• Almagro P, Calbo E, Ochoa de Echaguen A, et al. Mortality after hospitalization for COPD. Chest. 2002 May;121(5):1441–1448. doi: 10.1378/chest.121.5.1441
   PubMed Web of Science ®Google Scholar
• Gunen H, Hacievliyagil SS, Kosar F, et al. Factors affecting survival of hospitalised patients with COPD. Eur Respir J. 2005 Aug;26(2):234–241. doi: 10.1183/09031936.05.00024804
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Baldwin RC, Connolly MJ. Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing. 2005 Sep;34(5):491–496. doi: 10.1093/ageing/afi163
   PubMed Web of Science ®Google Scholar
• Piquet J, Chavaillon JM, David P, et al. High-risk patients following hospitalisation for an acute exacerbation of COPD. Eur Respir J. 2013 Feb 8;42(4):946–955. doi: 10.1183/09031936.00180312
   PubMed Web of Science ®Google Scholar
• Antonelli Incalzi R, Fuso L, De Rosa M, et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J. 1997 Dec;10(12):2794–2800. doi: 10.1183/09031936.97.10122794
   PubMed Web of Science ®Google Scholar
• Gudmundsson G, Ulrik CS, Gislason T, et al. Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries. Int J Chron Obstruct Pulmon Dis. 2012;7:571–576. doi: 10.2147/COPD.S34466
   PubMed Web of Science ®Google Scholar
• Connors AF Jr., Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):959–967. doi: 10.1164/ajrccm.154.4.8887592
   PubMed Web of Science ®Google Scholar
• Ng TP, Niti M, Tan WC, et al. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007 Jan 8;167(1):60–67. doi: 10.1001/archinte.167.1.60
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Rabe KF, Ferguson GT, et al. Reduced all-cause mortality in the ETHOS trial of budesonide/glycopyrrolate/formoterol for COPD: a randomized, double-blind, multi-center parallel-group study. Am J Respir Crit Care Med. 2020 Nov 30;203(5):553–564. doi: 10.1164/rccm.202006-2618OC
   Web of Science ®Google Scholar
• Andreas S, Taube C. Inhaled therapy reduces COPD mortality. ERJ Open Res. 2020 Oct;6(4):00634–2020. doi: 10.1183/23120541.00634-2020
   PubMedGoogle Scholar
• Wells JM, Criner GJ, Halpin DMG, et al. Mortality risk and serious cardiopulmonary events in moderate-to-severe COPD: post Hoc analysis of the IMPACT trial. Chronic Obstr Pulm Dis. 2023 Jan 25;10(1):33–45. doi: 10.15326/jcopdf.2022.0332
   PubMed Web of Science ®Google Scholar
• Parker CM, Voduc N, Aaron SD, et al. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J. 2005 Sep;26(3):420–428. doi: 10.1183/09031936.05.00136304
   PubMed Web of Science ®Google Scholar
• Pinto-Plata VM, Livnat G, Girish M, et al. Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD. Chest. 2007 Jan;131(1):37–43. doi: 10.1378/chest.06-0668
   PubMed Web of Science ®Google Scholar
• MacDonald MI, Shafuddin E, King PT, et al. Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease. The Lancet Respir Med. 2016 Feb;4(2):138–148. doi: 10.1016/S2213-2600(15)00509-3
   PubMed Web of Science ®Google Scholar
• Patel AR, Kowlessar BS, Donaldson GC, et al. Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013 Nov 1;188(9):1091–1099. doi: 10.1164/rccm.201306-1170OC
   PubMed Web of Science ®Google Scholar
• Halpin DM, Decramer M, Celli B, et al. Risk of nonlower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT(R) trial. Lung. 2011 Aug;189(4):261–268. doi: 10.1007/s00408-011-9301-8
   PubMed Web of Science ®Google Scholar
• Kunisaki KM, Dransfield MT, Anderson JA, et al. Exacerbations of chronic obstructive pulmonary disease and cardiac events. a post Hoc cohort analysis from the SUMMIT randomized clinical trial. Am J Respir Crit Care Med. 2018 Jul 1;198(1):51–57. doi: 10.1164/rccm.201711-2239OC
   PubMed Web of Science ®Google Scholar
• Dransfield MT, Criner GJ, Halpin DMG, et al. Time-dependent risk of cardiovascular events following an exacerbation in patients with chronic obstructive pulmonary disease: post hoc analysis from the IMPACT trial. J Am Heart Assoc. 2022 Sep 20;11(18):e024350. doi: 10.1161/JAHA.121.024350
   PubMed Web of Science ®Google Scholar
• Rizkallah J, Man SF, Sin DD. Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest. 2009 Mar;135(3):786–793. doi: 10.1378/chest.08-1516
   PubMed Web of Science ®Google Scholar
• Couturaud F, Bertoletti L, Pastre J, et al. Prevalence of pulmonary embolism among patients with COPD hospitalized with acutely worsening respiratory symptoms. JAMA. 2021 Jan 5;325(1):59–68. doi: 10.1001/jama.2020.23567
   PubMed Web of Science ®Google Scholar
• Agustí A, Celli BR, Criner GJ, et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Am J Respir Crit Care Med. 2023 Apr 1;207(7):819–837. doi: 10.1164/rccm.202301-0106PP
   PubMed Web of Science ®Google Scholar
• Lipson DA, Barnhart F, Brealey N, et al. Once-daily single-inhaler triple versus dual therapy in patients with COPD. N Engl J Med. 2018 May 3;378(18):1671–1680. doi: 10.1056/NEJMoa1713901
   PubMed Web of Science ®Google Scholar
• Rabe KF, Martinez FJ, Ferguson GT, et al. Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD. N Engl J Med. 2020 Jul 2;383(1):35–48. doi: 10.1056/NEJMoa1916046
   PubMed Web of Science ®Google Scholar
• Lipson DA, Crim C, Criner GJ, et al. Reduction in all-cause mortality with fluticasone furoate/umeclidinium/vilanterol in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2020 Jun 15;201(12):1508–1516. doi: 10.1164/rccm.201911-2207OC
   PubMed Web of Science ®Google Scholar
• The United States Food and Drug Administration. WARNING LETTER AstraZeneca pharmaceuticals LP. MARCS-CMS 664789 — AUGUST. 2023 Aug 04. Available from: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/astrazeneca-pharmaceuticals-lp-664789-08042023
   Google Scholar
• The U.S. Food and Drug Administration. Final summary minutes of the pulmonary-allergy drugs advisory committee meeting. 2020Aug 31. Available from: https://www.fda.gov/media/143921/download
   Google Scholar
• Suissa S. Perplexing mortality data from triple therapy trials in COPD. The Lancet Respir Med. 2021 Jul;9(7):684–685. doi: 10.1016/S2213-2600(21)00238-1
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Darken P, Dorinsky P. Perplexing mortality data from triple therapy trials in COPD - Author’s reply. The Lancet Respir Med. 2021 Oct;9(10):e96. doi: 10.1016/S2213-2600(21)00330-1
   PubMed Web of Science ®Google Scholar
• Singh D, Rabe KF, Martinez FJ, et al. Relationship between prior inhaled corticosteroid use and benefits ofbudesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung function in patients with chronic obstructive pulmonary disease: Analyses from the ETHOS study. Respir Med. 2022 Jun;197:106857. doi: 10.1016/j.rmed.2022.106857
   PubMed Web of Science ®Google Scholar
• Han MK, Criner GJ, Dransfield MT, et al. The effect of inhaled corticosteroid withdrawal and baseline inhaled treatment on exacerbations in the IMPACT study. a randomized, double-blind, multicenter clinical trial. Am J Respir Crit Care Med. 2020 Nov 1;202(9):1237–1243. doi: 10.1164/rccm.201912-2478OC
   PubMed Web of Science ®Google Scholar
• Pedersen TR, Kjekshus J, Berg K, et al. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the scandinavian simvastatin survival study (4S). 1994. Atherosclerosis Suppl. 2004 Oct;5(3):81–87. doi: 10.1016/j.atherosclerosissup.2004.08.027
   PubMed Web of Science ®Google Scholar
• Heart protection study collaborative G. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002 Jul 6;360(9326):7–22. doi: 10.1016/S0140-6736(02)09327-3
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Skeans MA, Wise RA, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005 Feb 15;142(4):233–239. doi: 10.7326/0003-4819-142-4-200502150-00005
   PubMed Web of Science ®Google Scholar
• Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13–64. doi: 10.1164/rccm.201309-1634ST
   PubMed Web of Science ®Google Scholar
• McCarthy B, Casey D, Devane D, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015 Feb 23;2(2):CD003793. doi: 10.1002/14651858.CD003793.pub3
   Google Scholar
• Ryrso CK, Godtfredsen NS, Kofod LM, et al. Lower mortality after early supervised pulmonary rehabilitation following COPD-exacerbations: a systematic review and meta-analysis. BMC Pulm Med. 2018 Sep 15;18(1):154. doi: 10.1186/s12890-018-0718-1
   PubMed Web of Science ®Google Scholar
• Puhan MA, Gimeno-Santos E, Cates CJ, et al. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016 Dec 08;12(12):CD005305. doi: 10.1002/14651858.CD005305.pub4
   PubMedGoogle Scholar
• Lindenauer PK, Stefan MS, Pekow PS, et al. Association between initiation of pulmonary rehabilitation after hospitalization for COPD and 1-year survival among medicare beneficiaries. JAMA. 2020 May 12;323(18):1813–1823. doi: 10.1001/jama.2020.4437
   PubMed Web of Science ®Google Scholar
• Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med. 1980 Sep;93(3):391–398. doi: 10.7326/0003-4819-93-3-391
   PubMed Web of Science ®Google Scholar
• Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet. 1981 Mar 28;1(8222):681–686. doi: 10.1016/S0140-6736(81)91970-X
   PubMed Web of Science ®Google Scholar
• Fletcher EC, Luckett RA, Goodnight-White S, et al. A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg. Am Rev Respir Dis. 1992 May;145(5):1070–1076. doi: 10.1164/ajrccm/145.5.1070
   PubMed Web of Science ®Google Scholar
• Gorecka D, Gorzelak K, Sliwinski P, et al. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia Thorax. Thorax. 1997 Aug;52(8):674–679. doi: 10.1136/thx.52.8.674
   PubMed Web of Science ®Google Scholar
• Chaouat A, Weitzenblum E, Kessler R, et al. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J. 1999 Nov;14(5):1002–1008. doi: 10.1183/09031936.99.14510029
   PubMed Web of Science ®Google Scholar
• Albert RK, Au DH, Blackford AL, et al. A randomized trial of long-term oxygen for COPD with moderate desaturation. N Engl J Med. 2016 Oct 27;375(17):1617–1627.
   PubMed Web of Science ®Google Scholar
• Lacasse Y, Sériès F, Corbeil F, et al. Randomized trial of nocturnal oxygen in chronic obstructive pulmonary disease. N Engl J Med. 2020 Sep 17;383(12):1129–1138. doi: 10.1056/NEJMoa2013219
   PubMed Web of Science ®Google Scholar
• Lacasse Y, Casaburi R, Sliwinski P, et al. Home oxygen for moderate hypoxaemia in chronic obstructive pulmonary disease: a systematic review and meta-analysis. The Lancet Respir Med. 2022 Nov;10(11):1029–1037. doi: 10.1016/S2213-2600(22)00179-5
   PubMed Web of Science ®Google Scholar
• Osadnik CR, Tee VS, Carson-Chahhoud KV, et al. Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017 Jul 13;7(7):CD004104. doi: 10.1002/14651858.CD004104.pub4
   PubMed Web of Science ®Google Scholar
• Kohnlein T, Windisch W, Kohler D, et al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. The Lancet Respir Med. 2014 Sep;2(9):698–705. doi: 10.1016/S2213-2600(14)70153-5
   PubMed Web of Science ®Google Scholar
• McEvoy RD, Pierce RJ, Hillman D, et al. Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. Thorax. 2009 May 7;64(7):561–566. doi: 10.1136/thx.2008.108274
   PubMed Web of Science ®Google Scholar
• Wilson M, Wang Z, Dobler CC, et al. Noninvasive positive pressure ventilation in the home (with addendum). Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Apr 2.
   Google Scholar
• Park SY, Yoo KH, Park YB, et al. The long-term efficacy of domiciliary noninvasive positive-pressure ventilation in chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials. Tuberc Respir Dis (Seoul). 2022 Jan;85(1):47–55. doi: 10.4046/trd.2021.0062
   PubMed Web of Science ®Google Scholar
• Leard LE, Holm AM, Valapour M, et al. Consensus document for the selection of lung transplant candidates: an update from the international society for heart and lung transplantation. J Heart Lung Transplant. 2021 Nov;40(11):1349–1379. doi: 10.1016/j.healun.2021.07.005
   PubMed Web of Science ®Google Scholar
• International Society for Heart and Lung Transplantation Registry. Adult lung transplantation statistics. 2019. https://www.ishlt.org/registries/international-thoracic-organ-transplant-(ttx)-registry
   Google Scholar
• Pirard L, Marchand E. Reassessing the BODE score as a criterion for listing COPD patients for lung transplantation. Int J Chron Obstruct Pulmon Dis. 2018;13:3963–3970. doi: 10.2147/COPD.S182483
   PubMed Web of Science ®Google Scholar
• Reed RM, Cabral HJ, Dransfield MT, et al. Survival of lung transplant candidates with COPD: BODE score reconsidered. Chest. 2018 Mar;153(3):697–701. doi: 10.1016/j.chest.2017.10.008
   PubMed Web of Science ®Google Scholar
• Vock DM, Durheim MT, Tsuang WM, et al. Survival benefit of lung transplantation in the modern era of lung allocation. Ann Am Thorac Soc. 2017 Feb;14(2):172–181. doi: 10.1513/AnnalsATS.201606-507OC
   PubMed Web of Science ®Google Scholar
• Thabut G, Ravaud P, Christie JD, et al. Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008 May 15;177(10):1156–1163. doi: 10.1164/rccm.200708-1283OC
   PubMed Web of Science ®Google Scholar
• Siddiqui FM, Diamond JM. Lung transplantation for chronic obstructive pulmonary disease: past, present, and future directions. Curr Opin Pulm Med. 2018 Mar;24(2):199–204. doi: 10.1097/MCP.0000000000000452
   PubMed Web of Science ®Google Scholar
• Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003 May 22;348(21):2059–2073.
   PubMed Web of Science ®Google Scholar
• Seamark DA, Seamark CJ, Halpin DM. Palliative care in chronic obstructive pulmonary disease: a review for clinicians. J R Soc Med. 2007 May;100(5):225–233. doi: 10.1177/014107680710000512
   PubMed Web of Science ®Google Scholar
• Celli BR, MacNee W, Agusti A. ATS ERS task force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004 Jun;23(6):932–946. doi: 10.1183/09031936.04.00014304
   PubMed Web of Science ®Google Scholar
• Halpin DMG. Palliative care for people with COPD: effective but underused. Eur Respir J. 2018 Feb;51(2):1702645. doi: 10.1183/13993003.02645-2017
   PubMed Web of Science ®Google Scholar
• Claessens MT, Lynn J, Zhong Z, et al. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to understand prognoses and preferences for outcomes and risks of treatments. J Am Geriatr Soc. 2000 May;48(5 Suppl):S146–53. doi: 10.1111/j.1532-5415.2000.tb03124.x
   PubMedGoogle Scholar
• Gardiner C, Gott M, Small N, et al. Living with advanced chronic obstructive pulmonary disease: patients concerns regarding death and dying. Palliat Med. 2009 Oct 13;23(8):691–697. doi: 10.1177/0269216309107003
   PubMed Web of Science ®Google Scholar
• Beckert L, Wiseman R, Pitama S, et al. What can we learn from patients to improve their non-invasive ventilation experience? ‘It was unpleasant; if I was offered it again, I would do what I was told’. BMJ Supportive & Palliative Care. 2020 Mar;10(1):e7. doi: 10.1136/bmjspcare-2016-001151
   PubMed Web of Science ®Google Scholar
• MacPherson A, Walshe C, O’Donnell V, et al. The views of patients with severe chronic obstructive pulmonary disease on advance care planning: a qualitative study. Palliat Med. 2013 Mar;27(3):265–272. doi: 10.1177/0269216312440606
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Seamark DA, Seamark CJ. Palliative and end-of-life care for patients with respiratory disease. Eur Respir Monograph. 2009;43:327–353.
   Google Scholar
• Halpin DMG. Clinical management of COPD in the real world: can studies reveal errors in management and pathways to improve patient Care? Pragmat Obs Res. 2023;14:51–61. doi: 10.2147/POR.S396830
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Dickens AP, Skinner D, et al. Identification of key opportunities for optimising the management of high-risk COPD patients in the UK using the CONQUEST quality standards: an observational longitudinal study. The Lancet Reg Health - Eur. 2023 Jun;29:100619. doi: 10.1016/j.lanepe.2023.100619
   PubMedGoogle Scholar